Openbookopenbook
Equity
American Oncology Network Inc.(AONC)
USD --+0.00%
Reward45Moderate
Risk65Medium-High
📊75%Data
Thin -0% profit margin · Revenue growing 51% YoY
AONC
+0.0 · +0.00%
USD · NASDAQ
American Oncology Network Inc. | Healthcare
Profitless Growth
Market Cap:336.36M
ℹ️
Reward Rating
45
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
65
Medium-High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on AONC to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is American Oncology Network Inc.?

, through its subsidiaries, provides oncology management services in the United States.

AONC · Verdict

Moderate reward · elevated risk

AONC stands out on growth and volatility, but watch the profitability signal.

Based on 88% data coverage

AONC · Verdict

What’s working & what to watch

Strengths 2

  • Growth72/100

    Rev +23.1% CAGR · earnings +235.7%

  • Volatility65/100

    Above average

Watchouts 4

  • Profitability9/100

    -0% net margin · -30% ROE

  • Valuation14/100

    Weak vs peers

  • Balance sheet19/100

    Net debt/EBITDA 46.6×

  • Cash flow30/100

    -1% free-cash-flow margin

Model-based scoring. For information only — not financial advice.

What is American Oncology Network Inc.?

, through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services, including nutrition guidance. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 336.36M.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (45)

The scoring profile indicates limited reward potential at this time, with growth and momentum offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap336.36M
P/E RatioN/A
Dividend YieldN/A
52 Week High14.25
52 Week Low0.0004
Last AnnualDecember
IPO Date5/5/2021
IncorporatedUSA
Shares Outstanding29M
No. of Employees1,914
IndustryMedical Care Facilities
ExchangeNASDAQ
Beta0.759
CurrencyUSD
Websitewww.aoncology.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.